NVIV, CVM, IWEB & Extended Watchlist

InVivo Therapeutics Holdings Corp. NVIV
NVIV has traded as low as 4.84 since the first time we talked about it back on Monday, July 15th, and after just five trading days, hit a high of 6.20 this past Monday.

We’re going to have this stock on our longer-term watchlist moving forward, and would like to see the stock maintain support above 5.00. The technologies they have developed have the potential to be game-changers in the field of spinal cord injury treatment.

Earlier this month, InVivo announced it would be teaming up with the New York Mets to create Major League Baseball’s first Spinal Cord Injury Awareness Day on Sunday, September 15th at Citi Field when the New York Mets host the Miami Marlins at 1:10 p.m. ET.

More Info @



We want to add CVM to our radars this morning. The stock hit its 52-low of .16 just prior to the closing bell yesterday afternoon, and this morning the company had some fresh news hit the wires. We want to watch this one closely, as conditions like these can often lead to significant bottom bounces.

Today’s PR:

CEL-SCI Corporation (NYSE MKT: CVM) announces the publication of the results of influenza studies by researchers from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) and CEL-SCI in the Journal of Clinical Investigation, a leading journal for discoveries in basic and clinical biomedical research (2013 J Clin Invest. doi: 10.1172/JCI67550 2013, supplemental information at www.jci.org/articles/view/67550). The studies described in the publication show that when CEL-SCI’s investigational J-LEAPS Influenza Virus treatments were used “in vitro” to activate immune cells called dendritic cells (DCs), these activated dendritic cells, when injected into influenza infected mice, arrested the progression of lethal influenza virus infection in these mice. >>> FULL STORY



Yesterday morning we stated our hope that IWEB would break through resistance at .0355- it did that and more. After touching an early morning low of .032, the stock went on a 22% intraday run, with shares trading at .039 at their peak.

In addition, the stock closed with strength (.036), above previous resistance at .0355, maintaining more than half of its daily gains on over 5X its 3mo. average volume, which is often a bullish signal.

From the low following our original alert of IWEB at .023, yesterday’s high represents an overall move of 70% Since that time, the cumulative gains attained by IWEB have amounted to more than 115% in possible profits.

BARCHART.COM has also upgraded its opinion of IWEB to a 72% Overall “Buy” Rating.

Extended Watchlist:

Comments are closed.